MyMelanoma Opens First Study
MyMelanoma Opens to Participants with
The MyMelaonoma Team are delighted to announce the opening of its first study arm. This study, led by Dr Antonia Pritchard at the University of the Highlands & Islands, seeks to understand the impact of hereditary features in the development of melanoma. Subsequently we are any individuals with a personal or family history suggestive of familial melanoma to participate in our study.
Our hope is that from this study we will better understand the clinical features associated with carrying a pathogenic variant in a gene known to increase melanoma risk in families and identify novel pathogenic variants that are associated with familial melanoma. With this information not only should we be able to improve the quality of care these families receive, but also identify novel therapeutic targets based on an improved understanding of melanoma biology.
To find out more about how to get involved and contribute to the project follow THIS link.